Fund moves
5.9%Stake
A Schedule 13G is filed by holders above 5% who say they will not try to influence the company. Index funds and large asset managers file most of them.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
XLAB · NASDAQ · Services-Prepackaged Software
Exascale Labs (XLAB) · oqro.io/stocks/XLAB · printed today. Every figure comes from a public filing, linked on the page online. Not investment advice.
No open-market purchase by an insider of Exascale Labs is on record in SEC filings since 2006.
No open-market sale by an insider of Exascale Labs (XLAB) was filed with the SEC in the last 90 days.
No trade in Exascale Labs (XLAB) was disclosed by a member of Congress in the last 12 months.
From official filings only: SEC Forms 4, 5 and 144 for insiders, House and Senate periodic transaction reports for Congress, SEC Form 13F for funds, Form 8-K for company events and USAspending for federal contracts. Every record on OQRO links to its source. It is public data, not investment advice.
$1.33−0.16 (−10.74%)
Close of Nov 20, 2026, vs Nov 19 · end-of-day
−74.1% (−$3.81) from Aug 28, 2026 to Nov 20, 2026 · adjusted daily closes
No disclosed open-market insider trades, politician trades or fund 13F changes in this period.
Adjusted close went from $5.14 on Aug 28, 2026 to $1.33 on Nov 20, 2026 (−74.1%). Disclosed in this range: 0 insider trades, 0 pre-arranged insider sales, 0 Congress trades.
Counts of filings OQRO holds, by the date each was filed or the award started. Every figure links to its official SEC, House, Senate or USAspending record.
Services-Prepackaged Software company based in Houston, Tx.
Last 12 months
Not enough history
Market value
$126M
Short interest: 709K shares sold short (0.7% of shares outstanding), +1706.5% vs the previous count, 1.0 days of normal trading to buy them back. FINRA, as of Oct 30, 2026. Short interest history
Revenue, fiscal 2026
$14.8M
+111.3% vs the year before
Net income, fiscal 2026
−$12.2M
A loss for the year
Shares outstanding
64.3M
As of Sep 25, 2026
Fund moves
A Schedule 13G is filed by holders above 5% who say they will not try to influence the company. Index funds and large asset managers file most of them.
Fund moves
A Schedule 13G is filed by holders above 5% who say they will not try to influence the company. Index funds and large asset managers file most of them.
Prices are daily closes from Polygon.io. Company figures come from its own SEC filings. Past moves are not a forecast. OQRO reports what was filed and never tells you what to buy or sell.
Top officer leaving
“Departure of Interim Chief Financial Officer Effective September 25, 2026, Gildas Bonnier ceased serving as the Interim Chief Financial Officer of Exascale Labs Holdings Inc.”
8-K on sec.govTop officer leaving
“The Consulting Agreement will continue until the earliest of (i) the date a permanent Chief Financial Officer of the Company begins service, (ii) termination by either party upon ten (10) days’ written notice to the other party or (iii) immediate termination by the Company for fraud, willful misconduct, gross negligence, material breach of the Consulting Agreement, violation of applicable law or m”
8-K on sec.govNotice of delisting or failure to meet listing rules
8-K on sec.govChanged auditor
8-K on sec.govFrom the company's 8-K, 10-K and 10-Q filings over the last two years. A flag is a reason to read the filing, not a verdict: many departures are planned retirements and many listing notices are resolved. Insider sales are shown for timing only; they are separate filings.
Revenue
$4.33M
+32.8% vs the same quarter a year earlier
Free cash flow, last 12 months
—
Cash from operations minus capital spending
Net debt
—
Debt —, cash $12.8M, at Sep 30, 2026
Net income, last 12 months
—
From the company's own quarterly and annual reports to the SEC. Free cash flow (cash from operations minus capital spending), net debt (debt minus cash) and 12-month totals are calculated by OQRO. Production rates, deliveries, approvals and guidance are in its results announcement of Sep 28, 2026.
ARC Group International Limited
13G · passive · Crossed 5% · 4.95M shares · filed Oct 15, 2026
Hack Seed Fund II LP
13G · passive · Crossed 5% · 2M shares · filed Oct 29, 2026
Recent moves
Source: SEC Schedules 13D and 13G, which anyone owning more than 5% of a class of stock must file. A 13D filer may seek to influence the company; a 13G filer is passive. Filings before December 2024 are free text and read from their cover page: a percent or share count that is not stated plainly is left blank. Each line links to the filing.
Written by OQRO's software from the last 12 months on record · Nov 19, 2026
Every number, name, date and link in the text above comes from this list; software checks that before the text is stored. This text was assembled directly from the facts, without a language model.
Funds and stakes
Contracts, lobbying and filings
Company reports, price and press
Deals
Fails to deliver: 330K shares (about $1.02M) were not delivered on time for settlement on Oct 28, 2026. SEC fails-to-deliver data.
Fails to deliver have many causes, including processing delays, and are often resolved within days.
Off-exchange trading: 66.6% of the shares traded over the latest 4 published weeks changed hands away from the exchanges (2.2% on ATS, 64.4% with other brokers), close to its 7-week average of 66.5%. Weeks of Sep 21 to Oct 16, 2026.
Things to keep in mind
Largest ATS: VIRTU MATCHIT ATS (19.3%), UBS ATS (16.7%), INTELLIGENT CROSS LLC (12.8%), as a share of this stock's ATS volume over the same 4 weeks.
An ATS, often called a dark pool, is a private trading venue run by a broker where orders are not shown publicly before they trade. Other off-exchange trades are mostly retail orders filled by wholesale brokers. A high share is common and says nothing by itself about where the price goes. FINRA OTC Transparency data, published 2 weeks after each week for the largest stocks and 4 weeks for others; total volume from our daily price data.
Latest annual report filed Sep 28, 2026. Read the filing
47 risk factor headings in this report. There is no earlier annual report to compare it with.
From time to time, we may be subject to legal proceedings. We are not currently a party to or aware of any proceedings that we believe will have, individually or in the aggregate, a material adverse effect on our business, financial condition or results of operations. Regardless of outcome, litigation can have an adverse impact on us because of defense and settlement costs, diversion of management resources and other factors.
Source: SEC EDGAR, Form 10-K filed Sep 28, 2026. Headings are the titles the company gives each risk; OQRO compares them with the year before by their words, so a heading that was reworded a lot shows up as both new and no longer listed. Companies list the risks they face, not forecasts.